Riik: Austraalia
keel: inglise
Allikas: APVMA (Australian Pesticides and Veterinary Medicines Authority)
AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE; CLAVULANIC ACID
NORBROOK LABORATORIES AUSTRALIA PTY LIMITED
amoxycillin as trihydrate(400mg/Tb) + others
ORAL TABLET
AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE ANTIBIOTIC Active 400.0 mg/Tb; CLAVULANIC ACID ANTIBIOTIC Active 100.0 mg/Tb
#100 Tabs; #250 Tabs; #Tub; *100 Tabs; *250 Tabs; *50 Tabs; *500 Tabs; *Blister
VM - Veterinary Medicine
CALF | DOG | BEEF CALF | BITCH | BOVINE | CALF - PODDY | CALF - PREWEANING | CALF - SUCKER | CASTRATE | DAIRY CALF | NEONATAL CA
ANTIBIOTIC & RELATED
BORDETELLA BRONCHISEPTICA | CORYNEBACTERIUM SPP. | ESCHERICHIA COLI (E. COLI) | KLEBSIELLA SPP. | PASTEURELLA SPP. | PROTEUS MIRABILIS | SALMONELLA | STAPHYLOCOCCUS SPP. | STREPTOCOCCUS SPP. | BACTERIAL CANKER | CANINE COUGH SYNDROME | INCLUDING B-LACTAMASE PRODUCIN | INFECTIOUS TRACHEOBRONCHITIS | PASTERELLOSIS | PASTEURELLOSIS | SALMONELLOSIS | STAPHYLOCOCCOSIS
Poison schedule: 4; Withholding period: WHP: (calves): MEAT: DO NOT USE less t han 4 days before slaughter for human c onsumption. Not for use in bobby calves .; Host/pest details: CALF: [BORDETELLA BRONCHISEPTICA, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., PASTEURELLA SPP., PROTEUS MIRABILIS, SALMONELLA, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]; DOG: [BORDETELLA BRONCHISEPTICA, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., PASTEURELLA SPP., PROTEUS MIRABILIS, SALMONELLA, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]; Poison schedule: 4; Withholding period: ; Host/pest details: CALF: [BORDETELLA BRONCHISEPTICA, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., PASTEURELLA SPP., PROTEUS MIRABILIS, SALMONELLA, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]; DOG: [BORDETELLA BRONCHISEPTICA, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., PASTEURELLA SPP., PROTEUS MIRABILIS, SALMONELLA, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]; For the treatment of bacterial infections sensitive to clavulanic acid and amoxycillin in dogs and calves.This product is contraindicated for use in small herbivores (e.g. rabbits, guinea pigs) or animals with a history of allergic reactions to penicillins. NOT FOR USE IN BOBBY CALVES.
Registered
2023-07-01
50 TABLETS Norbrooli ~ File Name: 55507 _ 4733_50C_Iabei_MPL_Ol Date Prepared: 16/ 6/09 Carton Dimensions (in mm): 79 x 66 x 118 Scale when printed on A4 paper: 66% Scale when printed on A3 paper: 100% APPROVED LABEL Info PEST Verified 100 Tablets Norbrooll :S File Name: 55507 _ 4733 _ 100C _ Iabei_MPL _ 01 Date Prepared: 16/6/09 Carton Dimensions (in mm): 115 x 83 x 124 Scale when printed on A4 paper: 66% Scale when printed on A3 paper: 100% 100 Tablets Norbrooll :S APPROVED LABEL File Name : 5550 7 _ 4 733 _1 O OT _ labei_ MP L_ 01 Date Prepared : 16 /6 /09 Label Dimensions (in mm) : 1 31.75 x 49 Scale when printed on A4 paper: 1 00% (~ NORBROOLI i APPROVED LABEL APPROVED LABEL File Name: Date Prepared: Label Dimensions (in mm): Scalewhen printed onA4 paper: 55507 4733 250T label MPL 01 16/6/09 - - - - 150 x 50 100% Expiry: READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT DIRECTIONS FOR USE: This product is conb'aindieated for use in small herbivores (eg. rabbits, guinea pigs) or animals with a p::c:.~r:3~~~:r:i~C;::~~.to penicillins. Dogs: 12.5 mg/kg bodyweight twice daily (1 tablet per 40 kg) for 5-7 days or 48 hours after clinical signs have subsided. ~~~~~~~:2Js~ 1~; h~~d=~~~~~ tr;'~~i~:I~~~~~%~:~~~r:~ ~~: bi,~:rs after clinical signs have Any variation by the prescribing veterinarian to the approved dose, frequency, duration, route, disease t:.f1~H~'6L"8~~~~%[l'~c"~~f"nding the approved withholding period. MEAT: DO NOT USE less than 4 days before slaughter for human consumption. Not for use in bobby calves. TRADE ADVICE: ~.:rm:,iA~~::'~~~~~~~ ~~ ~s=~~°u"~,:"'~~:";':~u~~ established. For advice on the FIRST AID: If POisoni~ occurs contact a doctor or Poisons I~rmatlon centre. Phone Australia 131 126. ~::::I~We2~ ~r ~~~~i~n'fr,rar.Ping with paper and putting in garbage. . ':::!!!S::!=!:!:iI Norbrook Laboratories Australia ~ limited @ . . ACN. 080 972 596 NORBROOLL .lS ~~~~rT;~:J{::t:e IIIIII "-- APV __ MA _: 5_55 _07 _12 _5 _OT _I_0 _50 _9 . . . .. -" TrialCode 123 APPROVED LABEL 55507 _ 4733_500C_labe Lugege kogu dokumenti
PRODUCT NAME: NOROCLAV 500MG TABLETS FOR DOGS AND CALVES PAGE: 1 OF 4 THIS REVISION ISSUED: AUGUST, 2008 MATERIAL SAFETY DATA SHEET Issued by: Norbrook Laboratories Australia Pty Ltd Freecall: 1800 665 866 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY NORBROOK LABORATORIES AUSTRALIA PTY LTD FREECALL: 1800 665 866 UNIT 7/1 TRADE PARK DRIVE TULLAMARINE, VIC 3043 AUSTRALIA SUBSTANCE: Clavulanic acid is biosynthetically generated from the amino acid arginine and the sugar glyceraldehyde 3-phosphate. Amoxycillin is a moderate-spectrum, bacteriolytic, β-lactam antibiotic. TRADE NAME: NOROCLAV 500MG TABLETS FOR DOGS AND CALVES PRODUCT USE: Oral treatment of bacterial infections caused by susceptible organisms in dogs and calves. CREATION DATE: AUGUST, 2008 REVISION DATE: AUGUST, 2008 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of ASCC. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S25. Avoid contact with eyes. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR : Circular, pink tablets. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. Significant ingredients in this product are antibiotics. Any person with a history of allergies to antibiotics should avoid contact with this product as it may cause sensitisation. POTENTIAL HEALTH EFFECTS Persons with a history of allergies to antibiotics should avoid contact with this product as it may cause sensitisation. INHALATION: SHORT TERM EXPOSURE: Long term inhalation of high amounts of any nuisance dust may overload lung clearance mechanism. Available data indicates that this product is not harmful. In Lugege kogu dokumenti